Development of Essential Thrombocythemia-Like Myeloproliferative Disorder in Transgenic Mice Overexpressing a Human 8-Oxoguanine DNA-Glycosylase Gene.

Qin Huang(People's Hospital of Xinjiang Uygur Autonomous Region), Chun‐Yang Fan(Soochow University), Lynn Doglio(Northwestern Memorial Hospital), Yubo Ma(Chinese Academy of Sciences), Haihong Zhang, Margie A. Scott(University of Arkansas for Medical Sciences), Steven A. Schichman(Central Arkansas Veterans Healthcare System), Lawrence M. Weiss(NeoGenomics (United States)), Philip M. Iannacone(Northwestern Memorial Hospital)

Blood

November 16, 2004

10.1182/blood.v104.11.791.791

Cited by 0

Related Papers

Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages

|Blood|2016|1.6k

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

|Blood|2013|683

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

|Blood|2012|396

Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver.

|Journal of Biological Chemistry|1993|375

Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

|Leukemia|2012|362